Journal of Asthma and Allergy
Volume 16, 2023 - Issue
Open access
229
Views
0
CrossRef citations to date
0
Altmetric
SHORT REPORT
Antitussive Use in Patients with Inadequately Controlled Moderate-to-Severe Asthma: A Post Hoc Analysis of the Omalizumab EXTRA Trial
Cedric J Rutland1 Rutland Medical Group, Newport Beach, CA, USAView further author information
, Onyinye I Iweala2 Division of Rheumatology, Allergy, and Immunology, University of North Carolina, Chapel Hill, NC, USA
https://orcid.org/0000-0001-7470-7904View further author information
Kyle Anders3 Genentech, Inc., South San Francisco, CA, USAView further author information
, Jinnie Ko3 Genentech, Inc., South San Francisco, CA, USAView further author information
, Parul Mital3 Genentech, Inc., South San Francisco, CA, USAView further author information
, Sachin Gupta3 Genentech, Inc., South San Francisco, CA, USACorrespondence[email protected]
View further author information
& View further author information
Arjun Mohan4 Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USAView further author information
show all
Pages 661-665
|
Received 06 Apr 2023, Accepted 14 Jun 2023, Published online: 24 Jun 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.